EricKoMD

PubMed

• Immunotherapy for head and neck cancer: where do we go from here?
  Eric C Ko, Glenn J Hanna> ;Immunotherapy. 2023 Dec 1
• Definitive Radiation Therapy for Medically Inoperable Endometrial Carcinoma.
  James L Shen, Kevin W O'Connor, Janaki Moni, Susan Zweizig, Thomas J Fitzgerald, Eric C Ko> ;Advances in Radiation Oncology. 2022 Oct 25
• Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed.
  James L Shen, Eric C Ko> ;Journal of Thoracic Disease. 2022 Jul 1
• 10 citations
  Radiotherapy and Immunotherapy Combinations for Lung Cancer
  Vishesh Agrawal, Kimberly Thomas Benjamin, Eric C. Ko> ;Current Oncology Reports. 2021 Jan 1
• Analysis of Pathologic Complete Response 10 Weeks After Radiotherapy-A Radiobiological Sin.
  Eric C. Ko, Claire Vanpouille-Box, Silvia C. Formenti> ;JAMA Oncology. 2019 Sep 1
• 48 citations
  Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality.
  Eric C. Ko, Silvia C. Formenti> ;International Journal of Radiation Biology. 2019 Jun 13
• 1 citations
  Radiation unlocks the therapeutic potential of immune checkpoint blockers in lung cancer patients
  Eric C. Ko, Lorenzo Galluzzi> ;Oncoimmunology. 2019 Apr 22
• 155 citations
  The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer
  Eric C. Ko, David Raben, Silvia C. Formenti> ;Clinical Cancer Research. 2018 Dec 1
• 42 citations
  Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation.
  Eric C. Ko, Kimberly Thomas Benjamin, Silvia C. Formenti> ;Advances in Radiation Oncology. 2018 Oct 1
• Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non-Small-Cell Lung Cancer.
  Eric C. Ko> ;Oncology. 2018 Sep 15
• 81 citations
  Radiotherapy and checkpoint inhibitors: a winning new combination?
  Eric C. Ko, Silvia C. Formenti> ;Therapeutic Advances in Medical Oncology. 2018 Apr 11
• First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinic...
  Richard K. Valicenti, Stephanie L. Pugh, Edouard J. Trabulsi, Oliver Sartor, Eric C. Ko, M.R. Girvigian, Seth A. Rosenthal, Mark E. Shaves, Jeannie H. Hoffman-Censits,...> ;International Journal of Radiation Oncology, Biology, Physics. 2018 Mar 1
• 8 citations
  Treatment strategies in low-volume metastatic castration-resistant prostate cancer.
  Xiao X. Wei, Eric C. Ko, Charles J. Ryan> ;Current Opinion in Urology. 2017 Nov 1
• 3 citations
  Postoperative Radiation After Radical Prostatectomy.
  Eric C. Ko, A.L. Michaud, Richard K. Valicenti> ;Seminars in Radiation Oncology. 2017 Jan 1
• 79 citations
  Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy
  Hui-Ming Chen, Ge Ma, Neil Gildener-Leapman, Samuel Eisenstein, Brian A. Coakley, Junko Ozao, John Mandeli, Celia M. Divino, Myron Schwartz, Max Sung, Robert L. Ferris...> ;Clinical Cancer Research. 2015 Apr 28
• 12 citations
  Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neck.
  T.J. Carpenter, Benjamin H. Kann, Michael Buckstein, Eric C. Ko, Richard L. Bakst, Krzysztof Misiukiewicz, Marshall R. Posner, Eric M. Genden, Vishal Gupta> ;The Annals of Otology, Rhinology, and Laryngology. 2014 May 20
• 47 citations
  Epidemiology of head and neck squamous cell cancer among HIV-infected patients.
  Gypsyamber D'Souza, Thomas E. Carey, William N. William, Minh Ly Nguyen, Eric C. Ko, James Riddell, Sara I. Pai, Vishal Gupta, Heather M. Walline, J. Jack Lee, Gregory...> ;Journal of Acquired Immune Deficiency Syndromes. 2014 Apr 15
• 2 citations
  Association of early PSA failure time with increased distant metastasis and decreased survival in prostate brachytherapy patients
  Eric C. Ko, Jerry Liu, Nelson N. Stone, Richard G. Stock> ;Radiotherapy and Oncology. 2014 Feb 1
• 24 citations
  Γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers
  Shibo Fu, Ying Yang, Das Tirtha, Yun Yen, Bing sen Zhou, Ming-Ming Zhou, Michael Ohlmeyer, Eric C. Ko, Ross L. Cagan, Barry S. Rosenstein, Shu Hsia Chen, Johnny Kao> ;Plos One. 2012 Jun 29
• 54 citations
  Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.
  Charles C. L. Tong, Eric C. Ko, Max W. Sung, Jamie A. Cesaretti, Richard G. Stock, Stuart Packer, Kevin Forsythe, Eric M. Genden, Myron Schwartz, K. H.Vincent Lau, Mat...> ;Plos One. 2012 Jun 27
• 28 citations
  PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure.
  Eric C. Ko, Nelson N. Stone, Richard G. Stock> ;International Journal of Radiation Oncology, Biology, Physics. 2012 Jun 1
• 7 citations
  Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated r...
  Charles C. L. Tong, K. H.Vincent Lau, Michael Rivera, David Cannan, Julio A. Aguirre-Ghiso, Andrew G. Sikora, Vishal Gupta, Kevin Forsythe, Eric C. Ko, Krzysztof Misiu...> ;Oncology Reports. 2012 May 1
• 9 citations
  Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation.
  Eric C. Ko, Eric M. Genden, Krzysztof Misiukiewicz, Peter M. Som, Lale Kostakoglu, Chien Ting Chen, Stuart Packer, Johnny Kao> ;Oncology Reports. 2011 Oct 21
• 11 citations
  Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy.
  Shibo Fu, Michael Rivera, Eric C. Ko, Andrew G. Sikora, Chien Ting Chen, Ha Linh Vu, David Cannan, Samuel Eisenstein, Barry S. Rosenstein, Julio A. Aguirre-Ghiso, Shu ...> ;Journal of Cell Science &amp; Therapy. 2011 Oct 13
• 19 citations
  Radiobiological rationale and clinical implications of hypofractionated radiation therapy
  Eric C. Ko, Kevin Forsythe, Michael Buckstein, Johnny Kao, Barry S. Rosenstein> ;Cancer Radiotherapie. 2011 Jun 1
• Join now to see all

Abstracts/Posters

• Adjusted risk stratification for Gleason score (GS) 8 prostate cancer patients treated with trimodality therapy
  Liu JT, Ko EC, Stone NN, Stock RG, ASTRO 2012, Boston, MA, USA
• The potential impact of medications on biochemical control following definitive management of prostate cancer
  Blacksburg SR, Ko EC, Stone NN, Stock RG, ASTRO 2012, Boston, MA, USA
• Association of genetic factors with PSA response in prostate cancer patients receiving definitive radiotherapy
  Ko E, Kerns SL, Stone NN, Stock RG, Ostrer H, Rosenstein BS, ASTRO 2012, Boston, MA, USA
• Quality of life with adjuvant radiotherapy following transoral robotic surgery (TORS) for head and neck cancer
  Carpenter TJ, Gupta V, Buckstein MH, Ko EC, Posner MR, Genden EM, ASTRO 2012, Boston, MA, USA
• PSA nadir of <0.5ng/ml following brachytherapy for early stage prostate adenocarcinoma predicts for freedom from PSA failure and distant metastasis
  Ko EC, Stone NN, Stock RG, ASTRO 2010, San Diego, CA, USA
• Early PSA failure time following brachytherapy predicts for decreased prostate-specific and overall survival
  Ko EC, Stone NN, Stock RG, ASTRO 2011, Miami Beach, FL, USA
• Join now to see all